Genpharmasec share news, announcements and annual reports
BSE: 531592Commercial Services & SuppliesSmall Cap
GENPHARMASEC LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1996
Last close ₹1.02up ₹0.03 (3.03%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹0.99.
2 Nov: open ₹1.00, high ₹1.03, low ₹0.98
52-week range of traded prices to 2 Nov 2026
₹0.75Low, 30 Mar 2026₹1.79High, 3 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹56 Cr3,222nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −1.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.50
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,52,702
Genpharmasec board meetings
162 filed, newest first. Page 2 of 4.
Aug 2023
Jun 2023
May 2023
30 May · Board meeting
Meeting on 5 Jun 202318 May · Board meeting
Meeting on 26 May 2023: audited results8 May · Board meeting
3 May · Board meeting
Meeting on 8 May 2023: increase in authorised capital
Mar 2023
30 Mar · Board meeting
Feb 2023
2 Feb · Board meeting
Meeting on 10 Feb 2023: quarterly results
Dec 2022
20 Dec · Board meeting
Meeting on 28 Dec 2022
Nov 2022
3 Nov · Board meeting
Meeting on 11 Nov 2022: quarterly results
Oct 2022
27 Oct · Board meeting
Meeting on 1 Nov 2022
Sep 2022
5 Sep · Board meeting
Aug 2022
10 Aug · Board meeting
10 Aug · Board meeting
3 Aug · Board meeting
Meeting on 10 Aug 2022: quarterly results
May 2022
27 May · Board meeting
27 May · Board meeting
18 May · Board meeting
Meeting on 27 May 2022: audited results and quarterly results
Mar 2022
26 Mar · Board meeting
Feb 2022
14 Feb · Board meeting
14 Feb · Board meeting
4 Feb · Board meeting
Meeting on 14 Feb 2022: quarterly results
Nov 2021
11 Nov · Board meeting
11 Nov · Board meeting
2 Nov · Board meeting
Meeting on 11 Nov 2021: quarterly results
Sep 2021
6 Sep · Board meeting
6 Sep · Board meeting
Aug 2021
5 Aug · Board meeting
Meeting on 12 Aug 2021: quarterly results
Jun 2021
29 Jun · Board meeting
22 Jun · Board meeting
Meeting on 29 Jun 2021: quarterly results